Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BMS-986504”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Looking for participantsNCT07076121
What this trial is testing

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb 470
Very early researchLooking for participantsNCT06883747
What this trial is testing

Clinical Trial of BMS-986504 in Recurrent GBM Patients

Who this might be right for
Glioblastoma WHO Grade IV
Nader Sanai 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07283705
What this trial is testing

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Who this might be right for
Phase 2 StudyBMS-986504MTAP-deleted Pancreatic Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06855771
What this trial is testing

BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 130
Early research (Phase 1)Looking for participantsNCT07077434
What this trial is testing

Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 32
Early research (Phase 1)Not Yet RecruitingNCT07382544
What this trial is testing

Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

Who this might be right for
Advanced CancerSolid Tumor
M.D. Anderson Cancer Center 36
Early research (Phase 1)Looking for participantsNCT06672523
What this trial is testing

Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion

Who this might be right for
Advanced Solid Tumors With Homozygous MTAP Deletion
Bristol-Myers Squibb 8
Large-scale testing (Phase 3)Looking for participantsNCT07063745
What this trial is testing

Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Who this might be right for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb 590